Atlas Trials

Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia

Clinical trial NCT07715253 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07715253
Sponsor
New York State Psychiatric Institute
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Schizoaffective DisorderSchizophreniform DisorderSchizophrenia
Start date
2026-12-01
Primary completion
2030-08-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.